A great announcement released last week on the Qbiotics website that human clinical trial (QB46C-H07) has recruited all patients for its Phase 2A Soft tissue sarcoma, with the final patient being administered Tigilanol Tiglate.
They expect that results will be released early 2025.
- Forums
- ASX - By Stock
- Qbiotics
Qbiotics, page-1228
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)